Phase II study of nab-paclitaxel with gemcitabine for relapsed/refractory small cell lung cancer
Overview of attention for article published in Frontiers in oncology, July 2024
Altmetric Badge
About this Attention Score
-
Good Attention Score compared to outputs of the same age (74th percentile)
-
High Attention Score compared to outputs of the same age and source (94th percentile)
Readers on
- mendeley
- 8 Mendeley